Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-W015764 |
Brand: | MCE |
CAS: | 55321-99-8 |
MDL | MFCD00233977 |
---|---|
Molecular Weight | 139.11 |
Molecular Formula | C5H5N3O2 |
SMILES | O=C(C1=NC=CN=C1O)N |
T-1105, a structural analogue of T-705, is a novel broad-spectrum viral polymerase inhibitor. T-1105 inhibits the polymerases of RNA viruses after being converted to ribonucleoside triphosphate (RTP) metabolite. T-1105 has antiviral activity against various RNA viruses. T-1105 can be formed by nicotinamide mononucleotide adenylyltransferase [1] [2] .
T-1105 has antiviral activity against various RNA viruses, including Zika virus (ZIKV), influenza virus, arenaviruses, bunyaviruses, West Nile virus (WNV), yellow fever virus (YFV), and foot-and-mouth disease virus (FMDV)
[1]
[2]
.
T-1105 has good anti-RNA virus activity with values
EC
50
of 17 μM and 24 μM for parainfluenza-3 virus and Punta Toro virus in MDCK cells
[3]
.
T-1105 is a potential inhibitor of Zika virus replication
[4]
.
T-1105 can inhibit the SFTSV replication with an value
IC
50
of 49 μM in Vero cells and is not affect cell viability in 0-3 μM
[5]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Cytotoxicity Assay [4]
Cell Line: | Vero cells |
Concentration: | 1-4 μM |
Incubation Time: | 72 h |
Result: | Had potential antiviral activity against ZIKV strain SZ01 with an value EC 50 of 97.5 μM in Vero cells. |
Cell Viability Assay [5]
Cell Line: | Vero cells |
Concentration: | 0-3 μM |
Incubation Time: | 4 h |
Result: | Did not affect cell viability in the test range (0-3 μM). |
T-1105 (Oral, 200 mg/kg, twice daily for 6 days) effectively inhibits the virus replication in the infected pigs [6] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Pigs [6] |
Dosage: | 200 mg/kg |
Administration: | Oral, 200 mg/kg, twice daily for 6 days |
Result: | Reduced Viremia and increased anti-FMD antibody titers, did not observe any clinical signs of FMD. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 25 mg/mL ( 179.71 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 7.1886 mL | 35.9428 mL | 71.8856 mL |
5 mM | 1.4377 mL | 7.1886 mL | 14.3771 mL |
10 mM | 0.7189 mL | 3.5943 mL | 7.1886 mL |
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (17.97 mM); Clear solution
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.